Company / Working Capital
Beta Bionics, Inc. Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$237.0M
FY2025
5-year range
$93.0M / $237.0M
FY2023-FY2025
Trend
+112.0%
vs FY2024
Sector context
#103 of 160
Health Care
What the data says
At $237M, Beta Bionics, Inc.'s working capital ranks #103 of 160 in the Health Care sector. Improved from $93M to $237M over the past 2 years.
Based on SEC 10-K filings.
$237M in FY2025.
Improved from $93M to $237M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#103 of 160 in Health CareTop 64% of 160This company $237.0M Sector average $757.1M
▼
-68.7% below sector average
Key checks
Key Insights
- In FY2025, working capital increased 112.0% year-over-year.
- Ranks #103 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $237.0M | +112.0% |
| FY2024 | $111.8M | +20.2% |
| FY2023 | $93.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026